Balıkesir Üniversitesi
Kütüphane ve Dokümantasyon Daire Başkanlığı

Goodman and Gilman's the pharmacological basis of therapeutics (Kayıt no. 29659)

MARC ayrıntıları
000 -LEADER
fixed length control field 09046nam a2200409 i 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 010316s2001 nyuaf b 001 0 eng c
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2001030728
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0071354697
040 ## - CATALOGING SOURCE
Original cataloging agency DNLM/DLC
Transcribing agency DLC
Modifying agency NLM
-- C#P
-- WSM
049 ## - LOCAL HOLDINGS (OCLC)
Holding library BAUN_MERKEZ
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM300
Item number .G644 2001
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 4
Item number .G6532 2001
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Edition number 21
245 00 - TITLE STATEMENT
Title Goodman and Gilman's the pharmacological basis of therapeutics
246 3# - VARYING FORM OF TITLE
Title proper/short title Goodman and Gilman's the pharmacological basis of therapeutics
Title proper/short title Pharmacological basis of therapeutics
250 ## - EDITION STATEMENT
Edition statement 10th ed. /
Remainder of edition statement editors, Joel G. Hardman, Lee E. Limbird ; consulting editor Alfred Goodman Gilman
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer McGraw-Hill Medical Pub. Division,
Date of production, publication, distribution, manufacture, or copyright notice [2001]
Date of production, publication, distribution, manufacture, or copyright notice ©2001
300 ## - PHYSICAL DESCRIPTION
Extent xxvii, 2,148 pages, [1] folded leaf of plate :
Other physical details illustrations (some color) ;
Dimensions 26 cm
336 ## - CONTENT TYPE
Content Type Term text
Content Type Code txt
Source rdacontent
337 ## - MEDIA TYPE
Media Type Term unmediated
Media Type Code unmediated
Source rdamedia
338 ## - CARRIER TYPE
Carrier Type Term volume
Carrier Type Code volume
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index
505 00 - FORMATTED CONTENTS NOTE
Title Contents
-- Sect. I General Principles
-- Introduction
Statement of responsibility / Alfred Goodman Gilman
Title 1 Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, and Elimination
Statement of responsibility / Grant R. Wilkinson
Title 2 Pharmacodynamics: Mechanisms of Drug Action and the Relationship Between Drug Concentration and Effect
Statement of responsibility / Elliott M. Ross, Terry P. Kenakin
Title 3 Principles of Therapeutics
Statement of responsibility / Alan S. Nies
Title 4 Principles of Toxicology and Treatment of Poisoning
Statement of responsibility / Curtis D. Klaassen
Title 5 Gene Therapy
Statement of responsibility / Christopher S. Rogers, Bruce A. Sullenger, Alfred L. George, Jr.
Title Sect. II Drugs Acting at Synaptic and Neuroeffector Junctional Sites
-- 6 Neurotransmission: The Autonomic and Somatic Motor Nervous Systems
Statement of responsibility / Brian B. Hoffman, Palmer Taylor
Title 7 Muscarinic Receptor Agonists and Antagonists
Statement of responsibility / Joan Heller Brown, Palmer Taylor
Title 8 Anticholinesterase Agents
Statement of responsibility / Palmer Taylor
Title 9 Agents Acting at the Neuromuscular Junction and Autonomic Ganglia
Statement of responsibility / Palmer Taylor
Title 10 Catecholamines, Sympathomimetic Drugs, and Adrenergic Receptor Antagonists
Statement of responsibility / Brian B. Hoffman
Title 11 5-Hydroxytryptamine (Serotonin): Receptor Agonists and Antagonists
Statement of responsibility / Elaine Sanders-Bush, Steven E. Mayer
Title Sect. III Drugs Acting on the Central Nervous System
-- 12 Neurotransmission and the Central Nervous System
Statement of responsibility / Floyd E. Bloom
Title 13 History and Principles of Anesthesiology
Statement of responsibility / Charles Beattie
Title 14 General Anesthetics
Statement of responsibility / Alex S. Evers, C. Michael Crowder
Title 15 Local Anesthetics
Statement of responsibility / William A. Catterall, Kenneth Mackie
Title 16 Therapeutic Gases: Oxygen, Carbon Dioxide, Nitric Oxide, and Helium
Statement of responsibility / Eric J. Moody, Brett A. Simon, Roger A. Johns
Title 17 Hypnotics and Sedatives
Statement of responsibility / Dennis S. Charney, S. John Mihic, R. Adron Harris
Title 18 Ethanol
Statement of responsibility / Michael F. Fleming, S. John Mihic, R. Adron Harris
Title 19 Drugs and the Treatment of Psychiatric Disorders: Depression and Anxiety Disorders
Statement of responsibility / Ross J. Baldessarini
Title 20 Drugs and the Treatment of Psychiatric Disorders: Psychosis and Mania
Statement of responsibility / Ross J. Baldessarini, Frank I. Tarazi
Title 21 Drugs Effective in the Therapy of the Epilepsies
Statement of responsibility / James O. McNamara
Title 22 Treatment of Central Nervous System Degenerative Disorders
Statement of responsibility / David G. Standaert, Anne B. Young
Title 23 Opioid Analgesics
Statement of responsibility / Howard B. Gutstein, Huda Akil
Title 24 Drug Addiction and Drug Abuse
Statement of responsibility / Charles P. O'Brien
Title Sect. IV Autacoids; Drug Therapy of Inflammation
-- Introduction
Statement of responsibility / Jason D. Morrow, L. Jackson Roberts II
Title 25 Histamine, Bradykinin, and their Antagonists
Statement of responsibility / Nancy J. Brown, L. Jackson Roberts II
Title 26 Lipid-Derived Autacoids: Eicosanoids and Platelet-Activating Factor
Statement of responsibility / Jason D. Morrow, L. Jackson Roberts II
Title 27 Analgesic-Antipyretic and Antiinflammatory Agents and Drugs Employed in the Treatment of Gout
Statement of responsibility / L. Jackson Roberts II, Jason D. Morrow
Title 28 Drugs Used in the Treatment of Asthma
Statement of responsibility / Bradley J. Undem, Lawrence M. Lichtenstein
Title Sect. V Drugs Affecting Renal and Cardiovascular Function
-- 29 Diuretics
Statement of responsibility / Edwin K. Jackson
Title 30 Vasopressin and Other Agents Affecting the Renal Conservation of Water
Statement of responsibility / Edwin K. Jackson
Title 31 Renin and Angiotensin
Statement of responsibility / Edwin K. Jackson
Title 32 Drugs Used for the Treatment of Myocardial Ischemia
Statement of responsibility / David M. Kerins, Rose Marie Robertson, David Robertson
Title 33 Antihypertensive Agents and the Drug Therapy of Hypertension
Statement of responsibility / John A. Oates, Nancy J. Brown
Title 34 Pharmacological Treatment of Heart Failure
Statement of responsibility / Henry Ooi, Wilson Colucci
Title 35 Antiarrhythmic Drugs
Statement of responsibility / Dan M. Roden
Title 36 Drug Therapy for Hypercholesterolemia and Dyslipidemia
Statement of responsibility / Robert W. Mahley, Thomas P. Bersot
Title Sect. VI Drugs Affecting Gastrointestinal Function
-- 37 Agents Used for Control of Gastric Acidity and Treatment of Peptic Ulcers and Gastroesophageal Reflux Disease
Statement of responsibility / Willemijntje A. Hoogerwerf, Pankaj J. Pasricha
Title 38 Prokinetic Agents, Antiemetics, and Agents Used in Irritable Bowel Syndrome
Statement of responsibility / Pankaj J. Pasricha
Title 39 Agents Used for Diarrhea, Constipation, and Inflammatory Bowel Disease; Agents Used for Biliary and Pancreatic Disease
Statement of responsibility / Syed Jafri, Pankaj J. Pasricha
Title Sect. VII Chemotherapy of Parasitic Infections
-- Introduction
Statement of responsibility / James W. Tracy, Leslie T. Webster, Jr.
Title 40 Drugs Used in the Chemotherapy of Protozoal Infections: Malaria
Statement of responsibility / James W. Tracy, Leslie T. Webster, Jr.
Title 41 Drugs Used in the Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections
Statement of responsibility / James W. Tracy, Leslie T. Webster, Jr.
Title 42 Drugs Used in the Chemotherapy of Helminthiasis
Statement of responsibility / James W. Tracy, Leslie T. Webster, Jr.
Title Sect. VIII Chemotherapy of Microbial Diseases
-- 43 Antimicrobial Agents: General Considerations
Statement of responsibility / Henry F. Chambers
Title 44 Antimicrobial Agents: Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections
Statement of responsibility / William A. Petri, Jr.
Title 45 Antimicrobial Agents: Penicillins, Cephalosporins, and Other [beta]-Lactam Antibiotics
Statement of responsibility / William A. Petri, Jr.
Title 46 Antimicrobial Agents: The Aminoglycosides
Statement of responsibility / Henry F. Chambers
Title 47 Antimicrobial Agents: Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents
Statement of responsibility / Henry F. Chambers
Title 48 Antimicrobial Agents: Drugs Used in the Chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease, and Leprosy
Statement of responsibility / William A. Petri, Jr.
Title 49 Antimicrobial Agents: Antifungal Agents
Statement of responsibility / John E. Bennett
Title 50 Antimicrobial Agents: Antiviral Agents (Nonretroviral)
Statement of responsibility / Frederick G. Hayden
Title 51 Antimicrobial Agents: Antiretroviral Agents
Statement of responsibility / Stephen P. Raffanti, David W. Haas
Title Sect. IX Chemotherapy of Neoplastic Diseases
-- Introduction
Statement of responsibility / Paul Calabresi, Bruce A. Chabner
Title 52 Antineoplastic Agents [and others]
Statement of responsibility / Bruce A. Chabner, David P. Ryan, Luis Paz-Ares
Title Sect. X Drugs Used for Immunomodulation
-- 53 Immunomodulators: Immunosuppressive Agents, Tolerogens, and Immunostimulants
Statement of responsibility / Alan M. Krensky, Terry B. Strom, Jaffrey A. Bluestone
Title Sect. XI Drugs Acting on the Blood and the Blood-Forming Organs
-- 54 Hematopoietic Agents: Growth Factors, Minerals, and Vitamins
Statement of responsibility / Robert S. Hillman
Title 55 Anticoagulant, Thrombolytic, and Antiplatelet Drugs
Statement of responsibility / Philip W. Majerus, Douglas M. Tollefsen
Title Sect. XII Hormones and Hormone Antagonists
-- 56 Pituitary Hormones and Their Hypothalamic Releasing Factors
Statement of responsibility / Keith L. Parker, Bernard P. Schimmer
Title 57 Thyroid and Antithyroid Drugs
Statement of responsibility / Alan P. Farwell, Lewis E. Braverman
Title 58 Estrogens and Progestins
Statement of responsibility / David S. Loose-Mitchell, George M. Stancel
Title 59 Androgens
Statement of responsibility / Peter J. Snyder
Title 60 Adrenocorticotropic Hormone; Adrenocortical Steroids and Their Synthetic Analogs; Inhibitors of the Synthesis and Actions of Adrenocortical Hormones
Statement of responsibility / Bernard P. Schimmer, Keith L. Parker
Title 61 Insulin, Oral Hypoglycemic Agents, and the Pharmacology of the Endocrine Pancreas
Statement of responsibility / Stephan N. Davis, Daryl K. Granner
Title 62 Agents Affecting Calcification and Bone Turnover: Calcium, Phosphate, Parathyroid Hormone, Vitamin D, Calcitonin, and Other Compounds
Statement of responsibility / Robert Marcus
Title Sect. XIII The Vitamins
-- Introduction
Statement of responsibility / Robert Marcus, Ann M. Coulston
Title 63 Water-Soluble Vitamins: The Vitamin B Complex and Ascorbic Acid
Statement of responsibility / Robert Marcus, Ann M. Coulston
Title 64 Fat-Soluble Vitamins: Vitamins A, K, and E
Statement of responsibility / Robert Marcus, Ann M. Coulston
Title Sect. XIV Dermatology
-- 65 Dermatological Pharmacology
Statement of responsibility / Eric L. Wyatt, Steven H. Sutter, Lynn A. Drake
Title Sect. XV Ophthalmology
-- 66 Ocular Pharmacology
Statement of responsibility / Sayoko E. Moroi, Paul R. Lichter
Title Sect. XVI Toxicology
-- 67 Heavy Metals and Heavy-Metals Antagonists
Statement of responsibility / Curtis D. Klaassen
Title 68 Nonmetallic Environmental Toxicants: Air Pollutants, Solvents and Vapors, and Pesticides
Statement of responsibility / Curtis D. Klaassen
Title App. I Principles of Prescription Order Writing and Patient Compliance
Statement of responsibility / Lauralea Edwards, Dan M. Roden
Title App. II Design and Optimization of Dosage Regimens: Pharmacokinetic Data
Statement of responsibility / Kenneth E. Thummel, Danny D. Shen
Title Index
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology
Topical term or geographic name as entry element Chemotherapy
Topical term or geographic name as entry element Pharmacology
Topical term or geographic name as entry element Drug Therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Goodman, Louis S.
Fuller form of name (Louis Sanford),
Dates associated with a name 1906-2000
Personal name Hardman, Joel G
Personal name Limbird, Lee E
Personal name Gilman, Alfred Goodman,
Dates associated with a name 1941-2015
900 ## - EQUIVALENCE OR CROSS-REFERENCE-PERSONAL NAME [LOCAL, CANADA]
Personal Name 32925
Numeration bağış
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Kitap
Mevcut
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Cost, normal purchase price Full call number Barcode Date last seen Price effective from Koha item type
        Non-fiction Mehmet Akif Ersoy Merkez Kütüphanesi Mehmet Akif Ersoy Merkez Kütüphanesi Genel Koleksiyon 20/03/2012 108.80 QV4 .G6532 2001 032925 22/12/2015 11/01/2015 Kitap
Bizi Sosyal Medyada Takip Edin